Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.16 USD | +5.52% | +13.73% | +4.39% |
Apr. 16 | Leerink Partners Starts AnaptysBio With Outperform Rating, $47 Price Target | MT |
Apr. 11 | Wells Fargo Initiates AnaptysBio With Overweight Rating, $56 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.01% | 574M | |
-2.64% | 103B | |
+1.65% | 95.28B | |
+1.46% | 22.15B | |
-15.55% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.74% | 16.05B | |
+5.33% | 13.68B | |
+34.15% | 12.17B |
- Stock Market
- Equities
- ANAB Stock
- News AnaptysBio, Inc.
- JPMorgan Adjusts Price Target on AnaptysBio to $28 From $30, Maintains Neutral Rating